| Clear Cell Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived90 of 90show fewer |
|---|
| → investigated in trials for | Nivolumabmonoclonal antibody 39 trials (25 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 38 trials (9 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal_antibody 32 trials (10 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 28 trials (5 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 25 trials (16 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 23 trials (20 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 21 trials (16 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 17 trials (9 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 14 trials (6 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal_antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall_molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal_antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adagrasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD-1 Monoclonal Antibody MEDI0680 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal_antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tandutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |